PhaseBio Pharmaceuticals logo
PhaseBio Pharmaceuticals PHAS
$ 0.13 7.4%

Quarterly report 2022-Q2
added 08-12-2022

report update icon

PhaseBio Pharmaceuticals Total Current Liabilities 2011-2024 | PHAS

Annual Total Current Liabilities PhaseBio Pharmaceuticals

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
27.9 M 15 M 8.48 M 4.58 M - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
27.9 M 4.58 M 14 M